CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast

Bibliographic Details
Main Authors: Rathore, Ankita Singh, Kumar, Sandeep, Konwar, Rituraj, Makker, Annu, Negi, M.P.S., Goel, Madhu Mati
Format: Online
Language:English
Published: Medknow Publications & Media Pvt Ltd 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248382/
id pubmed-4248382
recordtype oai_dc
spelling pubmed-42483822014-12-05 CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast Rathore, Ankita Singh Kumar, Sandeep Konwar, Rituraj Makker, Annu Negi, M.P.S. Goel, Madhu Mati Original Article Medknow Publications & Media Pvt Ltd 2014-09 /pmc/articles/PMC4248382/ /pubmed/25366203 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Rathore, Ankita Singh
Kumar, Sandeep
Konwar, Rituraj
Makker, Annu
Negi, M.P.S.
Goel, Madhu Mati
spellingShingle Rathore, Ankita Singh
Kumar, Sandeep
Konwar, Rituraj
Makker, Annu
Negi, M.P.S.
Goel, Madhu Mati
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
author_facet Rathore, Ankita Singh
Kumar, Sandeep
Konwar, Rituraj
Makker, Annu
Negi, M.P.S.
Goel, Madhu Mati
author_sort Rathore, Ankita Singh
title CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
title_short CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
title_full CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
title_fullStr CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
title_full_unstemmed CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
title_sort cd3+, cd4+ & cd8+ tumour infiltrating lymphocytes (tils) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
description
publisher Medknow Publications & Media Pvt Ltd
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248382/
_version_ 1613162249581494272